Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study (Q40644063)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 1997
edit
Language Label Description Also known as
English
Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study
scientific article published on December 1997

    Statements

    Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study (English)
    Molthoff CF
    Prinssen HM
    Kenemans P
    van Hof AC
    den Hollander W
    Verheijen RH
    1 December 1997
    2712-2720
    12 Suppl

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit